DRI Healthcare Trust (TSE:DHT.UN) Price Target Raised to C$22.00

DRI Healthcare Trust (TSE:DHT.UN) had its target price upped by equities research analysts at Stifel Nicolaus from C$21.00 to C$22.00 in a research note issued to investors on Thursday,BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. Stifel Nicolaus’ price target points to a potential upside of 33.50% from the stock’s current price.

DRI Healthcare Trust Trading Down 1.1%

Shares of TSE DHT.UN traded down C$0.18 during trading on Thursday, reaching C$16.48. The company had a trading volume of 4,279 shares, compared to its average volume of 35,068. DRI Healthcare Trust has a twelve month low of C$10.70 and a twelve month high of C$17.69. The stock has a 50-day moving average price of C$16.50 and a two-hundred day moving average price of C$15.91. The stock has a market capitalization of C$907.62 million, a PE ratio of -18.11 and a beta of 0.41.

About DRI Healthcare Trust

DRI Healthcare Trust is managed by DRI Capital Inc DRI a pioneer in global pharmaceutical royalty monetization. We provide uniquely favorable exposure for investors in the biopharma industry managing a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world and aiming to acquire dependable patent-protected cash flow streams derived from the sales of those important drugs while limiting the risks and costs connected to drug development. DRI has developed a disciplined strategy predicated on actively sourcing royalty streams on medically necessary products and proudly work with multiple repeat deal partners.DRI Healthcare Trust is an unincorporated open-ended trust governed by the laws of the Province of Ontario pursuant to a declaration of trust dated October 21 2020 as amended.DRI Healthcare Trusts units are listed and trade on the Toronto Stock Exchange under DHT.UN in Canadian dollars and under DHT.U in U.S.